MedPath

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Phase 3
Completed
Conditions
Muscle Spasticity
Cerebral Palsy
Pediatrics
Interventions
Biological: Botulinum Toxin Type A
Registration Number
NCT01603641
Lead Sponsor
Allergan
Brief Summary

This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric lower limb spasticity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
370
Inclusion Criteria
  • Minimum weight of 10 kilograms (kg)/22 pounds (lb)
  • Cerebral palsy with dynamic muscle contracture of the ankle
Read More
Exclusion Criteria
  • Muscular dystrophy, myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or mitochondrial disease
  • Uncontrolled epilepsy
  • Botulinum Toxin therapy of any serotype for any condition within the last 3 months
  • History of surgical intervention of the lower study leg within 1 year, or planned surgery of any limb during the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
BOTOX®Botulinum Toxin Type AParticipants received maximum of 5 treatments of intramuscular injections of BOTOX® (botulinum toxin Type A) into a single lower limb muscles or divided between both lower limb muscles or into the lower limb muscles and/or upper limb muscles at a minimum of 12 weeks apart. Treatment dosing was according to investigator judgment not to exceed a maximum of 8 unit per kilogram (U/kg) of body weight (not to exceed 300 U) in treatment Cycle 1. Dose could be increased to a maximum of 10 U/kg (not to exceed 340 U) in treatment Cycles 2-5. Participants received intramuscular injections of BOTOX® (botulinum toxin Type A) 4 or 8 U/kg into the lower limb in the previous study or were de novo participants who were not enrolled in the previous study.
Primary Outcome Measures
NameTimeMethod
Percentage of Participants With at Least One Treatment-emergent Adverse Event (TEAE)From first dose of study drug up to 12 weeks post last dose (Up to 60 weeks)

An adverse event (AE) was any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment. A TEAE was an AE that occurred after receiving the first dose of investigational product or an AE present prior to first dose but increased in severity during the Treatment Period.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (56)

The Children's Mercy Hospital

🇺🇸

Kansas City, Missouri, United States

St. Luke's Medical Center

🇵🇭

Quezon City, Philippines

Uniwersytecki Dzieciecy Szpita

🇵🇱

Białystok, Poland

Uniwersyteckie Centrum Kliniczne

🇵🇱

Gdansk, Poland

Philippine Children's Medical Center

🇵🇭

Quezon City, Philippines

Centrum Rehabilitacji Krok po Kroku

🇵🇱

Gdansk, Poland

Specjalistyczny Gabinet Neurologiczny

🇵🇱

Krakow, Poland

Centrum Medyczne "POMOC"

🇵🇱

Lodz, Poland

INTERMED, Lublin

🇵🇱

Lublin, Poland

CRH ŻAGIEL MED, Lublin

🇵🇱

Lublin, Poland

Szpital Wojewodzki Nr 2

🇵🇱

Rzeszow, Poland

Poradnia Rehab - Neurologiczneij dla Dzieci I Mlodziezy Aga

🇵🇱

Warsaw, Poland

NZOZ Mazowieckie Centrum

🇵🇱

Warsaw, Poland

Maharaj Nakorn ChiangMai Hospital

🇹🇭

ChiangMai, Thailand

Srinagarind Hospital, Khon Kaen University

🇹🇭

Khon Kaen, Thailand

Clinical Research Center of New Jersey

🇺🇸

Voorhees, New Jersey, United States

NW FL Clinical Research Group, LLC

🇺🇸

Gulf Breeze, Florida, United States

Axcess Medical Research, LLC

🇺🇸

Loxahatchee Groves, Florida, United States

ABS Health, LLC

🇺🇸

Pasadena, California, United States

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Harrison Clinical Management

🇺🇸

Pomona, California, United States

New England Institute for Clinical Research

🇺🇸

Stamford, Connecticut, United States

Kocaeli Üniversitesi

🇹🇷

Kocaeli, Turkey

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Associated Neurologists of Southern Connecticut, P.C.

🇺🇸

Fairfield, Connecticut, United States

Selçuk Üniversitesi

🇹🇷

Konya, Turkey

Tyumen Regional Hospital #2 - State Budget Healthcare Institution of Tyumen region

🇷🇺

Tyumen, Russian Federation

Philippine Orthopedic Center

🇵🇭

Quezon City, Philippines

Severance Hospital, Yonsei University Health System

🇰🇷

Seoul, Korea, Republic of

Ankara Diskapi Yildrim Beyazit

🇹🇷

Ankara, Turkey

Childrens Republic Hospital

🇷🇺

Kazan, Russian Federation

Smolensk Regional Hospital- Regional Budget State Healthcare institution

🇷🇺

Smolensk, Russian Federation

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Shirley Ryan Ability Lab

🇺🇸

Chicago, Illinois, United States

Children's Healthcare of Atlanta Children's Rehabilitation Associates

🇺🇸

Atlanta, Georgia, United States

Pediatric Neurology, P.A.

🇺🇸

Orlando, Florida, United States

Beaumont Children's Hospital Pediatric Research

🇺🇸

Royal Oak, Michigan, United States

NYU Hospital for Joint Diseases

🇺🇸

New York, New York, United States

OnSite Clinical Solutions, LLC

🇺🇸

Charlotte, North Carolina, United States

Columbia University Dept. of Rehab. & Regenerative Medicine

🇺🇸

New York, New York, United States

University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

Seattle Children's Hospital

🇺🇸

Seattle, Washington, United States

Marshfield Clinic

🇺🇸

Marshfield, Wisconsin, United States

Semmelweis Egyetem- Ortopédiai Klinika Karolina út 27

🇭🇺

Budapest, Hungary

Debrecen University Clinical Center, Orthopedic Clinic

🇭🇺

Debrecen, Hungary

Daegu Fatima Hospital

🇰🇷

Daegu, Korea, Republic of

Istituto IRCCS G. Salini

🇮🇹

Genoa, Italy

National Health Insurance Service Ilsan Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

PMG Research of Charlotte, LLC

🇺🇸

Charlotte, North Carolina, United States

Rady Children's Hospital San Diego

🇺🇸

San Diego, California, United States

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Road Runner Research

🇺🇸

San Antonio, Texas, United States

Baylor College of Medicine Texas Children's Hospital

🇺🇸

Houston, Texas, United States

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Hasbro Children's Hospital

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath